Tuberculosis — Worldwide/Unknown
The trial [a South African patient] joined was small — it enrolled only 109 patients — but experts are calling the preliminary results groundbreaking. The drug regimen tested on [her] has shown a 90% success rate against a deadly plague, extensively drug-resistant tuberculosis.
On Wednesday [14 Aug 2019], the Food and Drug Administration (FDA) effectively endorsed the approach, approving the newest of the 3 drugs used in the regimen. Usually, the World Health Organization adopts approvals
…
